| David Alfonso Gavito, MD | |
|
1009 N Georgetown St, Round Rock, TX 78664-3289 | |
| (844) 309-6385 | |
| Not Available |
| Full Name | David Alfonso Gavito |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 1009 N Georgetown St, Round Rock, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255777215 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | BP10047239 (Texas) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | R3676 (Texas) | Primary |
| Entity Name | Spindletop Mhmr Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952357550 PECOS PAC ID: 1658268321 Enrollment ID: O20040228000236 |
News Archive
Patients with type 2 diabetes fare significantly better if they are started on three medications at the time of diagnosis than if they are prescribed a single drug and have other therapies added later, a San Antonio researcher said June 22 at the 73rd Scientific Sessions of the American Diabetes Association in Chicago.
PolyMedix, Inc. has received a notice of no objection from Health Canada for the Company's Clinical Trial Application ("CTA") for its defensin mimetic antibiotic compound, PMX-30063. This notice of no objection allows for the initiation of human clinical studies in Canada. PMX-30063 is the first defensin mimetic antibiotic compound cleared to enter human clinical trials for systemic use, representing an entirely new class of antibiotic drugs.
Following the sudden death yesterday of the former French government minister Philippe Séguin, who suffered a fatal heart attack, aged 66, the European Society of Cardiology is warning the public of the dangers of leaving risk factors such as hyperlipidemia, hypertension or diabetes untreated. Other major risk factors for coronary artery disease are smoking or being overweight.
Every year, nearly 37 million Americans suffer from the sinus pressure, nasal congestion, cough and postnasal drip that accompany sinusitis.
Providing girls in rural Africa with a deworming drug could help reduce the spread of HIV, according to a study recently published in PLoS Neglected Tropical Diseases, the New York Times reports.
› Verified 4 days ago
| Entity Name | The Gulf Coast Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245285899 PECOS PAC ID: 6204821895 Enrollment ID: O20040414001641 |
News Archive
Patients with type 2 diabetes fare significantly better if they are started on three medications at the time of diagnosis than if they are prescribed a single drug and have other therapies added later, a San Antonio researcher said June 22 at the 73rd Scientific Sessions of the American Diabetes Association in Chicago.
PolyMedix, Inc. has received a notice of no objection from Health Canada for the Company's Clinical Trial Application ("CTA") for its defensin mimetic antibiotic compound, PMX-30063. This notice of no objection allows for the initiation of human clinical studies in Canada. PMX-30063 is the first defensin mimetic antibiotic compound cleared to enter human clinical trials for systemic use, representing an entirely new class of antibiotic drugs.
Following the sudden death yesterday of the former French government minister Philippe Séguin, who suffered a fatal heart attack, aged 66, the European Society of Cardiology is warning the public of the dangers of leaving risk factors such as hyperlipidemia, hypertension or diabetes untreated. Other major risk factors for coronary artery disease are smoking or being overweight.
Every year, nearly 37 million Americans suffer from the sinus pressure, nasal congestion, cough and postnasal drip that accompany sinusitis.
Providing girls in rural Africa with a deworming drug could help reduce the spread of HIV, according to a study recently published in PLoS Neglected Tropical Diseases, the New York Times reports.
› Verified 4 days ago
| Entity Name | Bluebonnet Trails Community Mhmr Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730135864 PECOS PAC ID: 5799775409 Enrollment ID: O20040514000751 |
News Archive
Patients with type 2 diabetes fare significantly better if they are started on three medications at the time of diagnosis than if they are prescribed a single drug and have other therapies added later, a San Antonio researcher said June 22 at the 73rd Scientific Sessions of the American Diabetes Association in Chicago.
PolyMedix, Inc. has received a notice of no objection from Health Canada for the Company's Clinical Trial Application ("CTA") for its defensin mimetic antibiotic compound, PMX-30063. This notice of no objection allows for the initiation of human clinical studies in Canada. PMX-30063 is the first defensin mimetic antibiotic compound cleared to enter human clinical trials for systemic use, representing an entirely new class of antibiotic drugs.
Following the sudden death yesterday of the former French government minister Philippe Séguin, who suffered a fatal heart attack, aged 66, the European Society of Cardiology is warning the public of the dangers of leaving risk factors such as hyperlipidemia, hypertension or diabetes untreated. Other major risk factors for coronary artery disease are smoking or being overweight.
Every year, nearly 37 million Americans suffer from the sinus pressure, nasal congestion, cough and postnasal drip that accompany sinusitis.
Providing girls in rural Africa with a deworming drug could help reduce the spread of HIV, according to a study recently published in PLoS Neglected Tropical Diseases, the New York Times reports.
› Verified 4 days ago
| Entity Name | Sabine Valley Regional Mhmr Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639232002 PECOS PAC ID: 0143202580 Enrollment ID: O20040601001132 |
News Archive
Patients with type 2 diabetes fare significantly better if they are started on three medications at the time of diagnosis than if they are prescribed a single drug and have other therapies added later, a San Antonio researcher said June 22 at the 73rd Scientific Sessions of the American Diabetes Association in Chicago.
PolyMedix, Inc. has received a notice of no objection from Health Canada for the Company's Clinical Trial Application ("CTA") for its defensin mimetic antibiotic compound, PMX-30063. This notice of no objection allows for the initiation of human clinical studies in Canada. PMX-30063 is the first defensin mimetic antibiotic compound cleared to enter human clinical trials for systemic use, representing an entirely new class of antibiotic drugs.
Following the sudden death yesterday of the former French government minister Philippe Séguin, who suffered a fatal heart attack, aged 66, the European Society of Cardiology is warning the public of the dangers of leaving risk factors such as hyperlipidemia, hypertension or diabetes untreated. Other major risk factors for coronary artery disease are smoking or being overweight.
Every year, nearly 37 million Americans suffer from the sinus pressure, nasal congestion, cough and postnasal drip that accompany sinusitis.
Providing girls in rural Africa with a deworming drug could help reduce the spread of HIV, according to a study recently published in PLoS Neglected Tropical Diseases, the New York Times reports.
› Verified 4 days ago
| Entity Name | Stat Md Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154851590 PECOS PAC ID: 0840565719 Enrollment ID: O20171003004071 |
News Archive
Patients with type 2 diabetes fare significantly better if they are started on three medications at the time of diagnosis than if they are prescribed a single drug and have other therapies added later, a San Antonio researcher said June 22 at the 73rd Scientific Sessions of the American Diabetes Association in Chicago.
PolyMedix, Inc. has received a notice of no objection from Health Canada for the Company's Clinical Trial Application ("CTA") for its defensin mimetic antibiotic compound, PMX-30063. This notice of no objection allows for the initiation of human clinical studies in Canada. PMX-30063 is the first defensin mimetic antibiotic compound cleared to enter human clinical trials for systemic use, representing an entirely new class of antibiotic drugs.
Following the sudden death yesterday of the former French government minister Philippe Séguin, who suffered a fatal heart attack, aged 66, the European Society of Cardiology is warning the public of the dangers of leaving risk factors such as hyperlipidemia, hypertension or diabetes untreated. Other major risk factors for coronary artery disease are smoking or being overweight.
Every year, nearly 37 million Americans suffer from the sinus pressure, nasal congestion, cough and postnasal drip that accompany sinusitis.
Providing girls in rural Africa with a deworming drug could help reduce the spread of HIV, according to a study recently published in PLoS Neglected Tropical Diseases, the New York Times reports.
› Verified 4 days ago
| Entity Name | Psych Matters Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285114454 PECOS PAC ID: 2365793395 Enrollment ID: O20181001002170 |
News Archive
Patients with type 2 diabetes fare significantly better if they are started on three medications at the time of diagnosis than if they are prescribed a single drug and have other therapies added later, a San Antonio researcher said June 22 at the 73rd Scientific Sessions of the American Diabetes Association in Chicago.
PolyMedix, Inc. has received a notice of no objection from Health Canada for the Company's Clinical Trial Application ("CTA") for its defensin mimetic antibiotic compound, PMX-30063. This notice of no objection allows for the initiation of human clinical studies in Canada. PMX-30063 is the first defensin mimetic antibiotic compound cleared to enter human clinical trials for systemic use, representing an entirely new class of antibiotic drugs.
Following the sudden death yesterday of the former French government minister Philippe Séguin, who suffered a fatal heart attack, aged 66, the European Society of Cardiology is warning the public of the dangers of leaving risk factors such as hyperlipidemia, hypertension or diabetes untreated. Other major risk factors for coronary artery disease are smoking or being overweight.
Every year, nearly 37 million Americans suffer from the sinus pressure, nasal congestion, cough and postnasal drip that accompany sinusitis.
Providing girls in rural Africa with a deworming drug could help reduce the spread of HIV, according to a study recently published in PLoS Neglected Tropical Diseases, the New York Times reports.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Alfonso Gavito, MD 2401 S 31st St, Temple, TX 76508-0001 Ph: (254) 724-2585 | David Alfonso Gavito, MD 1009 N Georgetown St, Round Rock, TX 78664-3289 Ph: (844) 309-6385 |
News Archive
Patients with type 2 diabetes fare significantly better if they are started on three medications at the time of diagnosis than if they are prescribed a single drug and have other therapies added later, a San Antonio researcher said June 22 at the 73rd Scientific Sessions of the American Diabetes Association in Chicago.
PolyMedix, Inc. has received a notice of no objection from Health Canada for the Company's Clinical Trial Application ("CTA") for its defensin mimetic antibiotic compound, PMX-30063. This notice of no objection allows for the initiation of human clinical studies in Canada. PMX-30063 is the first defensin mimetic antibiotic compound cleared to enter human clinical trials for systemic use, representing an entirely new class of antibiotic drugs.
Following the sudden death yesterday of the former French government minister Philippe Séguin, who suffered a fatal heart attack, aged 66, the European Society of Cardiology is warning the public of the dangers of leaving risk factors such as hyperlipidemia, hypertension or diabetes untreated. Other major risk factors for coronary artery disease are smoking or being overweight.
Every year, nearly 37 million Americans suffer from the sinus pressure, nasal congestion, cough and postnasal drip that accompany sinusitis.
Providing girls in rural Africa with a deworming drug could help reduce the spread of HIV, according to a study recently published in PLoS Neglected Tropical Diseases, the New York Times reports.
› Verified 4 days ago
Dr. Jeffrey Jasper Tramonte, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 300 University Blvd Bldg A, Round Rock, TX 78665 Phone: 512-509-0200 | |
Ms. Luanne Taylor, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1009 N Georgetown St, Round Rock, TX 78664 Phone: 512-244-8374 Fax: 512-244-8371 | |
Mr. John L. Troutner, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 302 University Blvd, Round Rock, TX 78665 Phone: 512-509-8404 Fax: 512-509-5328 | |
Dr. Michael Musgrove, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1201 Sam Bass Rd, Round Rock, TX 78681 Phone: 512-964-6992 Fax: 512-388-0373 | |
Dr. Elizabeth Anne Calvin, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1009 N Georgetown St, Round Rock, TX 78664 Phone: 512-255-1720 | |
Ms. Kerri Ann Halfant, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1009 N Georgetown St, Round Rock, TX 78664 Phone: 512-244-8374 Fax: 512-244-8371 | |
Christopher A. Masi, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 600 Round Rock West Drive, Suite 504, Round Rock, TX 78681 Phone: 512-502-5696 Fax: 512-502-5704 |